Literature DB >> 10349387

Primary pleomorphic adenoma of the external auditory canal diagnosed by fine needle aspiration cytology. A case report.

C Gerber1, G Zimmer, T Linder, B Schuknecht, D R Betts, R Walter.   

Abstract

BACKGROUND: Pleomorphic adenoma (PA) arising in the external auditory canal (EAC) is a very rare neoplasm, thought to be derived from ceruminous glands. CASE: A 43-year-old male presented with a slowly growing mass in the right EAC. Clinical and radiologic examinations showed a well-circumscribed tumor limited to the EAC, without a connection to the parotid gland. Fine needle aspiration cytology (FNAC) revealed the typical cytologic findings of PA. The diagnosis was confirmed by histologic examination.
CONCLUSION: This case illustrates that together with clinical and radiologic findings, primary PA of the EAC can confidently be diagnosed by FNAC.

Entities:  

Mesh:

Year:  1999        PMID: 10349387     DOI: 10.1159/000331106

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  4 in total

1.  Pleomorphic adenoma of the external auditory canal.

Authors:  Mehmet Koyuncu; Filiz Karagöz; Hizir Kiliaçarslan
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-12       Impact factor: 2.503

Review 2.  Pleomorphic Adenoma of External Auditory Canal: Case Report of First Endoscopic Resection and Literature Review.

Authors:  Sven Beckmann; Matthias S Dettmer; Marco D Caversaccio; Roland Giger; Lukas Anschuetz
Journal:  Medicina (Kaunas)       Date:  2020-05-20       Impact factor: 2.430

3.  Pleomorphic adenoma in the external auditory canal: Arising at an atypical location.

Authors:  Kripa Dongol; Utsav Raj Karki
Journal:  SAGE Open Med Case Rep       Date:  2021-12-08

4.  Primary pleomorphic adenoma of the external auditory canal: a case report and review of the literature.

Authors:  Chizu Saito; Takeharu Kanazawa; Takehiko Yamaguchi; Ken-Ichi Nakamura; Keiichi Ichimura
Journal:  Case Rep Otolaryngol       Date:  2014-04-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.